Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recov… (NCT05562999) | Clinical Trial Compass
CompletedPhase 4
Impact of Deep Neuromuscular Blockade During Total Hip Replacement Surgery on Postoperative Recovery and Immune Function
Netherlands100 participantsStarted 2022-11-18
Plain-language summary
Monocenter randomized controlled trial to compare the effect of deep neuromuscular blockade (NMB) versus moderate NMB during total hip replacement surgery on postoperative quality of recovery and innate immune function.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age of 18 years or older
* Scheduled for total hip replacement surgery under general anaesthesia
* Informed consent obtained
Exclusion Criteria:
* Insufficient control of the Dutch language to read the patient information and to fill out de questionnaires
* Known or suspected hypersensitivity to rocuronium or sugammadex
* Deficiency of vitamin K dependent clotting factors or coagulopathy
* Severe renal disease (creatinine clearance \<30 ml/min), including patients on dialysis
* Severe liver disease (Child-Pugh Classification C)
* Known or suspected neuromuscular disorders impairing neuromuscular function
* Women who are or may be pregnant or currently breastfeeding
* Chronic use of psychotropic drugs
* Use of immunomodulatory medication
What they're measuring
1
Quality of Recovery 40 (QoR-40) questionnaire score